In spite of the outstanding role of tobacco smoking in human carcinogenesis, it is difficult to reproduce its effects in experimental animals. Based on the knowledge that a variety of mechanisms account for a higher susceptibility to carcinogens early in life, we have developed a murine model in which mainstream cigarette smoke becomes convincingly carcinogenic. The standard model involves exposure to smoke for 4 months, starting after birth, followed by an additional 3-4 months in filtered air. We evaluated herein the time-and dose-dependent response, at 7.5 months of life, of Swiss H mice that had been exposed to smoke for either 1, 2 or 4 months after birth. A one-month exposure, corresponding to a period of intense alveolarization, was sufficient to induce most inflammatory, degenerative and preneoplastic pulmonary lesions, including emphysema and alveolar epithelial hyperplasia, blood vessel proliferation and hemangiomas, reflecting an early proangiogenic role of smoking, and microadenomas bearing ki-67-positive proliferating cells as well as urinary bladder epithelial hyperplasia. Two months of exposure were needed to induce pulmonary adenomas and urinary bladder papillomas in males only, which highlights a protective role of estrogens in urinary bladder carcinogenesis. Four months, which in humans would correspond to the postnatal period, puberty, adolescence and early adulthood, were needed to induce other lesions, including tubular epithelial hyperplasia of kidney, bronchial epithelial hyperplasia and especially pulmonary malignant tumors. These findings highlight the concept that preneoplastic and neoplastic lesions occurring in adulthood can be induced by exposure to smoke early in life.
Introduction
In spite of the dominant role of cigarette smoke (CS) in the epidemiology of lung tumors, tumors at other sites and other chronic degenerative diseases (1, 2) , it is very difficult to reproduce the noxious effects of this complex mixture in animal models. Mainstream cigarette smoke (MCS), which is generated from the combustion of tobacco leaves at 1200-1800°C, is inhaled by active smokers into their airways as an undiluted complex mixture of more than 8000 identified compounds of virtually any chemical family. Seventy-three of these compounds have been evaluated by the International Agency for Research on Cancer (IARC) to be carcinogenic in humans and/ or experimental animals (3) . Most studies investigating effects and modulation of MCS carcinogenicity use typical components, such as benzo(a)pyrene [B(a)P] as a prototype of polycyclic aromatic hydrocarbons, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and N′-nitrosonornicotine as prototypes of tobacco-specific nitrosamines and reactive oxygen species as prototypes of free radicals (3) .
The problems in demonstrating MCS carcinogenicity in experimental animals arise from the general difficulty to test complex mixtures rather than individual compounds and from the limitations of inhalation systems in rodents, also including the fact that rodents are obligate nasal breathers. Lifetime studies showed that the whole-body exposure to MCS is weakly tumorigenic in F344 rats (4) and B6C3F1 mice (5) . During the last decade, we developed a novel murine model that convincingly reproduces the carcinogenicity of MCS (6) and its modulation under conditions mimicking interventions either in current smokers and/or ex-smokers. A variety of agents were investigated in this medium-term bioassay, including dietary agents (7) (8) (9) (10) , anti-inflammatory drugs (7, 11, 12) , antidiabetic drugs (8, 13) and anticancer drugs (8, 14) .
Our model involves exposure of mice for 4 months, starting at birth, followed by a period of 3-4 months in filtered air in order to give enough time for the growth of histopathological lesions. Under these experimental conditions, the aforementioned studies (7) (8) (9) (10) (11) (12) (13) (14) used a total of 1025 mice, either untreated (448 sham-exposed mice) or exposed to MCS (577 MCS-exposed mice). Exposure to MCS increased, often to a statistically significant extent, the incidence of a variety of pulmonary alterations. These included emphysema, alveolar epithelial hyperplasia, bronchial epithelial hyperplasia, blood vessel proliferation, microadenomas, adenomas and malignant tumors, as well as histopathological alterations in other organs, such as parenchymal degeneration in the liver, tubular epithelial hyperplasia and adenomas in the kidney and epithelial hyperplasia and papillomas in the urinary bladder. In particular, the efficacy of the test system in inducing preneoplastic and neoplastic lesions in the lung was documented by the fact that the overall incidence of lung microadenomas was 38.3% in MCS-exposed mice versus 0.9% in sham-exposed mice (42.6-fold increase), and the overall incidence of adenomas was 25.5% in MCS-exposed mice versus 2.0% in sham-exposed mice (12.8-fold increase). The incidence of pulmonary malignant tumors, which were completely absent in sham-exposed mice, was 11.3% in MCS-exposed mice, accounting for a total of 165 foci of various histopathological nature. However, such an increase was not always statistically significant in the individual studies (15) .
The rationale for starting exposure to MCS at birth is that the lung is particularly vulnerable during the perinatal period. In fact, a tremendous oxidative challenge occurs at birth in the lung as a consequence of the sudden transition from the maternal mediated respiration of the fetus to the autonomous pulmonary respiration of the newborns, which leads to a significant increase of DNA adducts and oxidative DNA damage in the lung (16) . Luckily, these genomic alterations are partially compensated by upregulation of adaptive genes tending to attenuate DNA damage (16, 17) . Therefore, the oxidative damage that is characteristically induced by CS in the lung cumulates with the 'spontaneous', birth-related oxidative damage. In fact, administration of the antioxidant N-acetyl-L-cysteine (NAC) during pregnancy not only prevented genomic and post-genomic alterations at birth (16) but even the induction of tumors following exposure to MCS after birth (18, 19) . A similar cancer protective effect was observed with the other antioxidant ascorbic acid (19) . Further studies in mice showed that mice are more responsive to MCS when exposure occurs early in life rather than during adulthood (20) and that oxidative stress and the resulting DNA damage provide a major contribution to the high susceptibility of mice to CS early in life (21) . Other mechanisms may contribute to the enhanced susceptibility to CS early in life, such as the greater proliferation rate of organs in neonatal organs, changes in xenobiotic metabolism and alterations in DNA repair (6) .
Based on these premises, the goal of the present study was to evaluate the influence of the length of the postnatal period of exposure to MCS on the development of tumors and other histopathological alterations later in life. Our MCS tumorigenicity model had originally been designed to adopt an exposure period of 4 months, followed by recovery in filtered air for an additional 3-4 months (6). Such a scheme was like the model developed by Witschi et al., in which adult A/J mice are exposed to environmental CS (ECS) for 5 months, followed by recovery in filtered air for an additional 4 months (22) (23) (24) . Although it is obvious that exposure to MCS does not reproduce any realistic situation in humans, our neonatal carcinogenicity model uses MCS because smoking machines that generate ECS deliver a substantially lower amount of total particulate matter. Since exposure to MCS is laborious and time consuming, we aimed at checking whether exposure of neonatal mice for shorter time periods after birth may affect the response in terms of tumors and other histopathological alterations in the lung and other organs.
Materials and methods

Mice
Thirty-two Swiss strain H pregnant mice generated a total of 279 neonatal mice (147 males and 132 females), which were born at the Animal Laboratory of the National Center of Oncology (Sofia, Bulgaria). The mice were housed in Makrolon™ cages on sawdust bedding. The dams and post-weaning mice were maintained on a standard rodent chow (Kostinbrod, Bulgaria) and allowed drinking water ad libitum. Housing, breeding and treatment of mice were in accordance with European (86/609/EEC Directive) and institutional guidelines.
Experimental groups
The 32 litters were randomly divided into four experimental groups. These included (a) 67 untreated mice kept in filtered air for 7.5 months (shamexposed mice), (b) 72 mice exposed to MCS, starting within 12 h after birth and continuing daily during the first month of life, followed by an additional 6.5 months in filtered air (mice exposed to MCS for 1 month), (c) 70 mice exposed to MCS, starting within 12 h after birth and continuing daily during the first 2 months of life, followed by an additional 5.5 months in filtered air (mice exposed to MCS for 2 months) and (d) 70 mice exposed to MCS, starting within 12 h after birth and continuing daily during the first 4 months of life, followed by an additional 3.5 months in filtered air (mice exposed to MCS for 4 months). The size of experimental groups allowed a statistical power of 90% to detect differences of at least 20% in the incidence of histopathological alterations given an alpha error of 0.05.
Exposure of mice to MCS
The mice belonging to Groups b, c and d were exposed whole-body to the MCS generated by commercially available cigarettes (Melnik King Size, Bulgartabac). These cigarettes have a declared content of 9.0 mg tar and 0.8 mg nicotine and deliver 10 mg CO each. MCS was transferred into 22.5 l sealed glass chambers, where the mice were exposed by drawing 15 consecutive puffs, each of 60 ml and lasting 6 s. Each daily session involved six consecutive exposures, lasting 10 min each, with 1-min intervals, during which a total air change was achieved in order to avoid excessive toxicity. The average concentration of total particulate matter in the exposure chambers was 543 mg/m 3 .
Collection of organs and evaluation of histopathological alterations
The mice that became sick or moribund before the end of the experiment were isolated from the other mice, and the mice surviving at 7.5 months of age were euthanized by CO 2 asphyxiation. Both the mice that died prematurely and the mice that were euthanized after 7.5 months were subjected
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cigarette smoke ECS environmental cigarette smoke MCS mainstream cigarette smoke NAC N-acetyl-L-cysteine to complete necropsy. Lungs, liver, kidney, urinary bladder and all organs with suspected macroscopic lesions were collected and fixed in 10% formalin. Each organ was cut into standardized sections, stained with hematoxylin and eosin and subjected to standard histopathological analysis. In particular, a total of 10 lung sections per mouse were analyzed, including two pieces each of the accessory, middle and caudal lobes of the right lung and the cranial lobe, which was left uncut, whereas the left lung was cut into three pieces. Four sections of liver, three sections of each kidney and two sections of urinary bladder were analyzed. The histological slides were scored blind by two expert pathologists. The yield of histopathological lesions was expressed both as incidence, indicating the number and percent of each histopathological lesion, and additionally as multiplicity for those lesions, such as microadenomas, adenomas and malignant tumors, which may be characterized by multiple foci.
Immunohistochemical detection of ki-67
Sections of lung from mice, either unexposed or exposed to MCS for either 1, 2 or 4 months (three male mice per group) were subjected to standard immunohistochemical analysis for the detection of the nuclear protein ki-67, using the MIB-5 antibody, which labels mouse ki-67 antigen (Dako, Agilent Technologies, Santa Clara, CA).
Statistical analysis
Comparisons between treatment groups regarding frequency data, including survival of mice and incidence of each histopathological lesion within each gender, were made by χ 2 analysis. Body weights and multiplicity of microadenomas, adenomas and malignant tumors were expressed as mean ± SE of the data generated within the mice composing each experimental group. Comparisons between groups regarding body weights were made by ANOVA and Student's t test for unpaired data. Differences with P < 0.05 were taken as statistically significant.
Results
Survival and body weights
Of the 277 mice under study, 34 (12.2%) died spontaneously before the age of 7.5 months, in most cases due to leukemia, irrespectively of exposure to MCS. In any case, a complete necropsy was carried out within 12 h after death also in these prematurely dead mice. There was no significant difference in survival among the 8 experimental groups. In particular, survival at 7.5 months of age in control mice and in mice exposed for 1, 2 and 4 months after birth was 87.5, 88.6, 90.2 and 90.2%
in males, and 81.5, 83.8, 89.7 and 88.9% in females, respectively. Figure 1 shows the body weight growth (means ± SE), measured at monthly intervals, in the mice belonging to the eight experimental groups. As compared to sham-exposed mice, there was a slight but statistically significant decrease of body weight during the periods of exposure to MCS in both male and female mice. Such a decrease was transient and, in all groups, body weights were no longer significantly different from those measured in sham-exposed mice the month following discontinuation of exposure to MCS. Figure 2 shows the results relative to the histopathological analysis of the lung, kidney and urinary bladder in terms of incidence, and provides examples of histopathological appearance of the lesions are shown next to each graph. The time-related and cumulative dose-dependent multiplicity of lung microadenomas, adenomas and malignant tumors is shown in Figure 3 .
Histopathological analysis of mice
No suspected lesions were macroscopically detectable in other organs, excepting some liver alterations (see below). In the lung, there was a time-dependent increase in the incidence of bronchial epithelial hyperplasia, which became statistically significant in both male and female mice exposed to MCS during the first 4 months of life, as compared to the sham-exposed mice of the same gender. Likewise, there was an increase in the incidence of both emphysema and alveolar epithelial hyperplasia, which was statistically significant on the first month of exposure to MCS and continued to grow in a time-dependent manner after 2 and 4 months. An increased proliferation of pulmonary blood vessels was statistically significant since the first month in males and since the second month in females, and thereafter did not increase further. The angiogenic role of MCS was also supported by the occurrence of lung hemangiomas, which reached the statistically significant threshold on the first month but in males only. As to microadenomas, both incidence and multiplicity were strongly and significantly increased in both males and females, with a trend to reach a plateau after 2 months of exposure to MCS. The occurrence of lung adenomas in MCS-exposed mice was also evident, although multiplicity was much lower than that of microadenomas. The increase of adenoma incidence was statistically Curves showing the body growth curves in male and female mice, either unexposed (Sham, empty circles) or exposed to MCS for either 1 (full squares), 2 (full triangles) or 4 (full circles) months, starting at birth and thereafter kept in filtered air for either 6.5, 5.5 or 3.5 months, respectively. significant in males exposed for either 2 or 4 months, whereas the increase in females became significant after 4 months only. On the other hand, this intergender difference was counterbalanced by a higher multiplicity of adenomas in females, in which the increase was statistically significant in mice exposed for either 1, 2 or 4 months, without any difference between 2 and 4 months, whereas in males the increase in adenoma multiplicity reached the statistical significance threshold after exposure for 2 months only. Malignant tumors were detectable after 2 and 4 months of exposure, when the carcinogenic response became statistically significant in both genders. In particular, while no cancer was detected in sham-exposed mice and in mice exposed for 1 month, a total of 21 malignant tumors were detected in five males and six females exposed for either 2 or 4 months. These tumors included 10 foci of adenosquamous carcinoma, six foci of bronchioloalveolar carcinomas, two foci each of adenocarcinoma and squamous cellular carcinoma and 1 focus of squamous cellular carcinoma in situ.
In the liver, some cases of parenchymal degeneration and blood vessel proliferation in MCS-exposed mice did not reach the statistical significance threshold compared to shamexposed mice (data not shown). As shown in Figure 2 , the increase in the incidence of tubular epithelial hyperplasia in the kidney became significant after 4 months of exposure to MCS in both genders. An early response of the urinary bladder to MCS was documented by an evident increase in the incidence of papillary hyperplasia, which was significant after 1 month in both genders. Urinary bladder papillomas were also detected, with a time-dependent trend, after exposure of mice during the first two months of life. However, induction by MCS of this type of lesion was considerably higher in males than in females, in which the statistically significant threshold was not attained (Figure 2 ). After 2 months of exposure to MCS, one carcinoma in situ and one papillary transition cell carcinoma were detected in females.
Immunohistochemical detection of ki-67
These analyses had the objective of evaluating, from a qualitative point of view, the effect of exposure to MCS on the proliferation of pulmonary cells and especially of those forming microadenomas, which are preneoplastic lesions that are mainly due to MCS-related inflammation. Figure 4 shows examples of immunohistochemical detection of ki-67 in lung sections from mice, either unexposed (A) or exposed to MCS for 2 months (B). Exposure to MCS resulted in hyperplasia of the alveolar epithelium and in the formation of a microadenoma, where several proliferating cells, showing a brown nuclear staining, were detectable.
Discussion
The results of the present study show the time course formation and the cumulative dose dependence of histopathological lesions in neonatal mice exposed to MCS early in life, for varying periods of time, and then kept in filtered air in order to detect these lesions later in life. In the interpretation of these results it should be taken into account that the previously described genomic and postgenomic alterations that 'physiologically' occur in the lung at birth (16, 17) are followed by a phase of remodeling and maturation of the lung during the lactation period, which in mice approximately covers the first month of life until completion of weaning. The lactation period partially overlaps with pre-adolescence (23-35 days) and is then followed by mid-adolescence (36-48 days) and post-adolescence (49-61 days) (25) , leading thereafter to sexual maturity and early adulthood. In humans, that period would cover the natal and postnatal periods, followed by puberty, adolescence and adulthood.
Of the pulmonary alterations caused by exposure of neonatal mice to MCS, the incidence of alveolar epithelial hyperplasia was already increased in the mice exposed during the first month of life and progressively increased in mice exposed for 2 and 4 months until affecting the majority of MCS-exposed mice, both males and females. This type of lesion consists in the proliferation of type II pneumocytes, which are progenitors of type I pneumocytes that are particularly vulnerable to oxidative stress. The proliferation of alveolar type II pneumocytes markedly increases during the first 2 weeks of life and thereafter declines (26) . Alveolarization in mice occurs during the first 12 days of postnatal life (27) and in humans continues throughout childhood and adolescence, until young adulthood (28) . In particular, the number of alveoli in the human lung is in the range 17-70 million at birth and 200-600 million in adults (29) .
A similar trend, but with a lower incidence, was observed with emphysema, a condition included within chronic obstructive pulmonary diseases that involves the enlargement of airspaces distal to terminal bronchioles accompanied by destruction of alveolar walls (30) . Such a condition typically develops in smokers due to several factors, such as an abnormal inflammatory response, a protease-antiprotease imbalance, oxidative stress and apoptosis (31) .
On the other hand, stimulation by MCS of bronchial epithelial hyperplasia, which involves an increase in the numbers of cells lining the inner surfaces of the bronchi, was less evident. The differentiated human airway epithelium consists of different cell types forming a pseudostratified and polarized epithelium formed by 50-70% ciliated cells, 11% Clara cells, up to 25% goblet cells and up to 30% basal cells. In vitro, a CS extract reduced the number of ciliated cells, while it increased the number of Clara and goblet cells (32) . The decrease in the number of ciliated cells may impair the mucociliatory transport, whereas the increase in the number of Clara cells may play a role in lung carcinogenesis because these cells include a subpopulation of bronchiolar tissue-specific stem cells and potential tumor initiating cells (33) .
Another evident effect on the lung resulting from exposure of mice to MCS since birth was an increase in blood vessel proliferation and of lung hemangiomas, an effect that was particularly evident in males. Cigarette smoking bears a strong etiological association with many neovascularization-related diseases such as cancer, cardiovascular diseases and macular degeneration, the pro-angiogenic activity of nicotine being mediated by nicotinic acetylcholine receptors (34) . A CS condensate induced in vitro the activator protein-1 (AP-1)-associated interleukin-8 (IL-8) and vascular endothelial growth factor in oral keratinocyte and laryngeal squamous carcinoma cells (35) . Proangiogenic factors, such as vascular endothelial growth factor, play a prominent role in the normal growth and development of the pulmonary circulation not only in the fetus but also in the newborn (36) , and disturbance of homeostasis by inhaled MCS may cause vascular alterations in the lung. It has been shown that the lung tissue from mice exposed to ECS for 12 weeks exhibited significantly increased vascular density (37) . The proangiogenic role of MCS in the lung of mice of the same strain used in the present study was also documented by modulation of microRNAs that are known to be involved in angiogenesis, which were found to be specifically dysregulated both in MCS-induced lung adenomas (miR-10b, miR-123 and miR-205) and malignant tumors (let7a and miR-378) (38) .
As to preneoplastic and neoplastic alterations, exposure to MCS caused an early and progressive increase in both incidence and multiplicity of microadenomas, with a striking yield after 2 and 4 months of exposure. The proliferative nature of these lesions was shown by the presence of several cells positive for ki-67 in the nucleus, a short lived non-histone protein that is expressed during the active phases of the cell cycle (G1, S and G2/M), whereas it is absent in the resting phase (G0) (39) . Microadenomas, which are larger than hyperplastic foci but are only detectable at the microscope, are preneoplastic lesions that may regress spontaneously (40) . Presumably, they result from MCS-related inflammation, a key mechanism in CS carcinogenesis (41) , as also shown by the ability of anti-inflammatory drugs to reduce the yield of these lesions (12) .
In addition, MCS caused an increase in lung adenoma incidence, especially after 2 and 4 months of exposure, with a higher susceptibility of males in terms of incidence and a higher susceptibility of females in terms of multiplicity. Adenomas mostly originate from type II pneumocytes (42) . Although these lesions are usually considered to be benign tumors, papillary adenomas, which were the most frequent in MCS-exposed mice, are likely to invade surrounding tissues, spread within the lungs via bronchioles and, in rare instances, metastasize to other organs (43) . The yield of malignant lung tumors of various histopathological nature became significantly higher in MCS-exposed mice of both genders, as compared with sham-exposed mice, after exposure of mice during the first 4 months of life, followed by recovery in filtered air for an additional 3.5 months.
As to the induction of extrapulmonary lesions, it is noteworthy that exposure of mice to MCS did not induce any liver tumor, which is in line with the indications of all our previous studies (15) . This result is consistent with the finding that exposure of rats to ECS induced the formation of bulky DNA adducts in various organs but not in the liver (44) . In addition, while exposure to ECS caused an extensive downregulation of microRNAs in the lung, mixed upregulation/downregulation effects were observed in the liver (45) .
Consistently with all our previous studies, exposure of mice to MCS caused significant alterations in the urinary tract. In the present study, the increase in the incidence of tubular epithelial hyperplasia in the kidney required 4 months of exposure to MCS to become statistically significant, whereas a considerable increase in the incidence of papillary epithelial hyperplasia of the urinary bladder occurred earlier in both genders and did not further progress after 2 months. On the other hand, MCS remarkably caused the formation of urinary bladder papillomas in male mice only. This intergender difference confirms the result of a previous study in MCS-exposed mice of the same strain (46) . Several lines of evidence support a role for sex hormones in modulating the growth and the development of bladder cancer (47), and a higher incidence of bladder cancer was observed in nitrosamine-exposed rats treated with testosterone as compared with rats treated with either estradiol or estriol (48) . Estrogens are able to reduce chronic bladder inflammation (48) , which, taking into account the key role of inflammation in CS-related carcinogenesis (41, 49) , may explain the lower susceptibility of females towards induction of urinary bladder papillomas by MCS.
In conclusion, just few alterations, including tubular epithelial hyperplasia of kidney, bronchial epithelial hyperplasia and especially pulmonary malignant tumors, required a 4-month exposure period to MCS to become statistically significant as compared to sham-exposed mice. All other histopathological alterations were induced after shorter exposure periods, and most of them, excepting pulmonary adenomas, were detectable in 7.5-month old mice that had been exposed during the first month of life only. Therefore, from a methodological point of view, a 1-month exposure period appears to be sufficient to induce most inflammatory, degenerative and preneoplastic lesions both in the lung and urinary tract. However, 2-4 months of exposure are needed to induce neoplastic lesions in the lung. In addition to the enhanced susceptibility at birth, continuation of exposure to MCS of mice during the first 4 months of life, involving a greater cumulative exposure dose, may have contributed to an increased development of tumors, consistently with the hypotheses raised in humans. In fact, certain lung diseases of the adult may have their roots in early stages of life (50) , and early smoking initiation confers an increased lung cancer risk (29, 51) , to such an extent that up to 52.4% of lung cancer cases in men and up to 73.0% of lung cancer cases in women may be attributed to the effect of first smoking at early age (52) .
Funding
